Related Experiment Video
Updated: Jan 17, 2026

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Ischemic Colitis Induced by Concurrent Non-steroidal Anti-inflammatory Drug (NSAID) and Corticosteroid Use for Back
Yusuf Almascati1, Ali Alhumaiqani1, Bernard Wen1
1Internal Medicine, King Hamad American Mission Hospital, A'ali, BHR.
Abstract:
Ischemic colitis is a multifactorial condition typically seen in older adults with risk factors for vascular disease and hypoperfusion, but it can also occur in healthier individuals due to medication-induced mucosal injury. We discuss a case of a 55-year-old male who developed right-sided ischemic colitis following two weeks of high-dose nonsteroidal anti-inflammatory drug (NSAID) use, combined with systemic corticosteroids for back pain. He presented with severe abdominal pain and bright red rectal bleeding, with labs suggestive of inflammation, initially raising the concern for gastritis and infectious colitis. Imaging showed nonspecific, acute mucosal inflammation, but endoscopic evaluation with biopsies confirmed the diagnosis of ischemic colitis, rather than infectious colitis. Conservative management with bowel rest, IV fluids, pain medications, and antibiotics led to a full recovery, with complete healing of mucosal ischemia on follow-up colonoscopy. This case demonstrates the potential for drug-induced ischemic colitis in patients without classic causes and focuses on the importance of careful medication review in patients presenting with acute colitis.
More Related Videos
05:18Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...